CryoLife Says SEC Inquiry Tied to Recall
- Share via
CryoLife Inc., which processes human tissue for transplant, said it is under investigation by the Securities and Exchange Commission after a sweeping federal recall of the company’s tissues last week.
CryoLife, based in Atlanta, said the SEC has requested information on its accounting practices and trading in company shares in the last 11 months, a period in which health officials are investigating how the company handled tissue.
Its shares, which were halted before the news, rose 6 cents to $3.05 on the New York Stock Exchange.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
